Literature DB >> 1578137

Role of a streptococcal antigen in the pathogenesis of acute poststreptococcal glomerulonephritis. Characterization of the antigen and a proposed mechanism for the disease.

N Yoshizawa1, S Oshima, I Sagel, J Shimizu, G Treser.   

Abstract

We studied the significance of a streptococcal protein (preabsorbing Ag) (PA-Ag) in the pathogenesis of acute poststreptococcal glomerulonephritis (APSGN). This protein was isolated from nephritogenic streptococci. Purification of PA-Ag was achieved by chromatography, followed by Sephadex IEF. A single protein band at pH 4.7 was identified as PA-Ag. The m.w. was 43,000. Rabbit antisera against PA-Ag and sera of patients with APSGN showed identical precipitation lines by immunodiffusion. Antibodies to PA-Ag were found to be present in 30 of 31 patients with APSGN, in 1 of 36 patients with uncomplicated group A streptococcal upper respiratory tract infections, and in 1 of 36 normal adults. By using immunoelectrophoresis, it was found that PA-Ag activates the alternate pathway of C. Other water-soluble streptococcal fractions, used as controls, did not activate the C system. The demonstration that PA-Ag is present in the glomeruli in the early phase of APSGN and its ability to activate C3 and factor B suggest that PA-Ag may be involved in the pathogenesis of APSGN, via in situ C activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1578137

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Allele substitution of the streptokinase gene reduces the nephritogenic capacity of group A streptococcal strain NZ131.

Authors:  A Nordstrand; W M McShan; J J Ferretti; S E Holm; M Norgren
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 2.  Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis.

Authors:  T Matthew Eison; Bettina H Ault; Deborah P Jones; Russell W Chesney; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2010-07-23       Impact factor: 3.714

3.  Acute poststreptococcal glomerulo-nephritis in general practice: the contribution of infection to its onset and course.

Authors:  P M Higgins
Journal:  Epidemiol Infect       Date:  1996-04       Impact factor: 2.451

4.  Acute post-streptococcal glomerulonephritis in a renal allograft.

Authors:  J M Sorof; N Weidner; D Potter; A A Portale
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

5.  Clonal diversity of Streptococcus pyogenes within some M-types revealed by multilocus enzyme electrophoresis.

Authors:  A M Haase; A Melder; J D Mathews; D J Kemp; M Adams
Journal:  Epidemiol Infect       Date:  1994-12       Impact factor: 2.451

6.  Identification of a survival-promoting peptide in medium conditioned by oxidatively stressed cell lines of nervous system origin.

Authors:  T J Cunningham; L Hodge; D Speicher; D Reim; C Tyler-Polsz; P Levitt; K Eagleson; S Kennedy; Y Wang
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

7.  Streptokinase as a mediator of acute post-streptococcal glomerulonephritis in an experimental mouse model.

Authors:  A Nordstrand; M Norgren; J J Ferretti; S E Holm
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

8.  Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri.

Authors:  F Boisgérault; J Mounier; V Tieng; M C Stolzenberg; I Khalil-Daher; M Schmid; P Sansonetti; D Charron; A Toubert
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 9.  An update on acute postinfectious glomerulonephritis worldwide.

Authors:  Talerngsak Kanjanabuch; Wipawee Kittikowit; Somchai Eiam-Ong
Journal:  Nat Rev Nephrol       Date:  2009-05       Impact factor: 28.314

Review 10.  Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis.

Authors:  Anjali A Satoskar; Samir V Parikh; Tibor Nadasdy
Journal:  Nat Rev Nephrol       Date:  2019-08-09       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.